Effect of combined treatment with the epirubicin-incorporating micelles (NC-6300) and 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016) on a human gastric cancer model
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of combined treatment with the epirubicin-incorporating micelles (NC-6300) and 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016) on a human gastric cancer model
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 135, Issue 1, Pages 214-223
Publisher
Wiley
Online
2013-12-04
DOI
10.1002/ijc.28651
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NC-6300, an epirubicin-incorporating micelle, extends the antitumor effect and reduces the cardiotoxicity of epirubicin
- (2013) Amane Takahashi et al. CANCER SCIENCE
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
- (2013) Tom Waddell et al. LANCET ONCOLOGY
- Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy
- (2012) Priyambada Parhi et al. DRUG DISCOVERY TODAY
- Co-delivery of daunomycin and oxaliplatin by biodegradable polymers for safer and more efficacious combination therapy
- (2012) Haihua Xiao et al. JOURNAL OF CONTROLLED RELEASE
- A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours
- (2011) R Plummer et al. BRITISH JOURNAL OF CANCER
- Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer
- (2011) Ken Kato et al. INVESTIGATIONAL NEW DRUGS
- First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
- (2011) Eric J. Feldman et al. JOURNAL OF CLINICAL ONCOLOGY
- Multimodal Assessment of Painful Peripheral Neuropathy Induced by Chronic Oxaliplatin-Based Chemotherapy in Mice
- (2011) Cynthia L Renn et al. Molecular Pain
- Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effect
- (2010) Yasuhiro Matsumura ADVANCED DRUG DELIVERY REVIEWS
- Improved anti-tumor activity of stabilized anthracycline polymeric micelle formulation, NC-6300
- (2010) Mitsunori Harada et al. CANCER SCIENCE
- Detailed Distribution of NK012, an SN-38-Incorporating Micelle, in the Liver and Its Potent Antitumor Effects in Mice Bearing Liver Metastases
- (2010) A. Takahashi et al. CLINICAL CANCER RESEARCH
- Phase I Study of NK012, a Novel SN-38-Incorporating Micellar Nanoparticle, in Adult Patients with Solid Tumors
- (2010) T. Hamaguchi et al. CLINICAL CANCER RESEARCH
- Synergistic antitumor activity of the SN-38-incorporating polymeric micelles NK012 with S-1 in a mouse model of non-small cell lung cancer
- (2010) Tatsuya Nagano et al. INTERNATIONAL JOURNAL OF CANCER
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Polymer-Caged Nanobins for Synergistic Cisplatin−Doxorubicin Combination Chemotherapy
- (2010) Sang-Min Lee et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Preclinical and clinical studies of anticancer agent-incorporating polymer micelles
- (2009) Yasuhiro Matsumura et al. CANCER SCIENCE
- Antitumor Activity of NK012 Combined with Cisplatin against Small Cell Lung Cancer and Intestinal Mucosal Changes in Tumor-Bearing Mouse after Treatment
- (2009) T. Nagano et al. CLINICAL CANCER RESEARCH
- Combination antitumor effects of micelle-loaded anticancer drugs in a CT-26 murine colorectal carcinoma model
- (2009) Hee Sam Na et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Antitumor Effect of SN-38-Releasing Polymeric Micelles, NK012, on Spontaneous Peritoneal Metastases from Orthotopic Gastric Cancer in Mice Compared with Irinotecan
- (2008) T. Eguchi Nakajima et al. CANCER RESEARCH
- Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil
- (2008) Takako Eguchi Nakajima et al. INTERNATIONAL JOURNAL OF CANCER
- Long-Term Benefit of High-Dose Epirubicin in Adjuvant Chemotherapy for Node-Positive Breast Cancer: 15-Year Efficacy Results of the Belgian Multicentre Study
- (2008) Evandro de Azambuja et al. JOURNAL OF CLINICAL ONCOLOGY
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More